The Types segmentation classifies devices by their delivery method and functional architecture, encompassing transcutaneous, implanted, neuromodulation, and portable stimulators. Transcutaneous units, which deliver current through surface electrodes, capture the largest portion of the market due to their ease of use and lower regulatory burden, supporting both research and clinical protocols. Implanted stimulators, surgically positioned for chronic stimulation, serve niche but high‑value segments such as long‑term pain mitigation and neuromuscular re‑education, contributing a modest share of revenue. Neuromodulation devices, integrating advanced waveforms and feedback control, are increasingly adopted in precision research and specialized therapeutic regimens, reflecting a growing premium segment. Portable stimulators, characterized by battery operation and lightweight design, address field‑based veterinary practice and on‑farm applications, adding flexibility to the market portfolio. Each type aligns with specific user requirements, collectively influencing the total market valuation and informing product development strategies within the Animal Electrical Stimulator taxonomy.